The ability of certain cells to migrate to sites of injury or inflammation.
The capacity of injected cells to migrate toward damaged or inflamed tissue and settle there rather than elsewhere in the body. Homing relies on chemical gradients (chemokines) and cell-surface receptors; it's not automatic. Many clinics assume homing happens without measuring where cells actually go; in reality, most injected cells lodge in non-target organs (lungs, liver) or are cleared by the immune system. Ask clinics whether they've performed imaging (PET, MRI) or biodistribution studies showing cells reach the target site and persist there. Homing is real but inconsistent; honest clinics acknowledge this uncertainty.
StemCellAtlas is your guide to stem-cell therapy: what the evidence shows, which conditions are treated, and the real all-in cost by country — typically €3,000–8,000 with our partner Stem Plus (Sofia), Europe's lowest-cost EU destination, versus $15,000–35,000 in the US.
Get an honest assessment